Charles Bush-Joseph, M.D., Medical Director at Midwest Orthopaedics at Rush (MOR) and head team physician for the Chicago White Sox, has been awarded an honorary membership from the National Athletic Trainers Association (NATA). According to the MOR website, “The award is given once a year to individuals who have shown profound interest in and have significant contributions to the profession of athletic training. They also display a dedication to advancing, promoting and championing the efforts of the association and its membership.”
Charles Bush-Joseph, M.D. Honored by National Athletic Trainers Association

An associate team physician for the Chicago Bulls, Dr. Bush-Joseph has cared for high school, collegiate and recreational athletes as a MOR physician partner for more than 30 years. He is also a professor at Rush University Medical Center and associate director of the Rush Orthopaedic Sports Medicine Fellowship Program. Dr. Bush-Joseph is also a member of the Major League Baseball Medical Advisory Board and was president of the Major League Baseball Team Physician Association in 2012.
Dr. Bush-Joseph told OTW, “To receive this recognition from the National Athletic Trainer’s Association is a great honor. The NATA represents over 35, 000 athletic trainers worldwide who work with, treat, and train athletes of every level, every day. As one of only three physicians inducted into their society for 2015, I find myself in exclusive company and cherish the honor.”
“In my first year of practice as a volunteer physician for a local high school, the experienced athletic trainer took me under his wing and allowed me to gain experience in his training room for the care and treatment of his athletes. Over the past 25 years I have had the good fortune to work with many skilled trainers at every level including those caring for professional athletes. The efficiency, skill, compassion, demonstrated by these professionals are the same I pass on to our orthopedic residents and fellows.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.